0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Isoxsuprine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-14R8294
Home | Market Reports | Health| Pharmacy
Global Isoxsuprine Market Insights Forecast to 2028
BUY CHAPTERS

Global Isoxsuprine Market Research Report 2025

Code: QYRE-Auto-14R8294
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Isoxsuprine Market

The global market for Isoxsuprine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Isoxsuprine (used as isoxsuprine hydrochloride) is a drug used as a vasodilator in humans (under the trade name Duvadilan) and equines. Isoxsuprine is a β2 adrenoreceptor agonist that causes direct relaxation of uterine and vascular smooth muscle via β2 receptors.
North American market for Isoxsuprine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Isoxsuprine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Isoxsuprine include Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb, Merck Sharp and Dohme, Amriya, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Isoxsuprine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoxsuprine.
The Isoxsuprine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Isoxsuprine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isoxsuprine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Isoxsuprine Market Report

Report Metric Details
Report Name Isoxsuprine Market
Segment by Type
  • Use in Humans
  • Use in Animals
Segment by Application
  • Peripheral Vasodilator
  • β-Sympathomimetic Agent
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb, Merck Sharp and Dohme, Amriya, Pfizer, Winston Pharma, Johnson and Johnson, Aspen Pharmacare, Abbott, Drugmaker's Laboratoires
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Isoxsuprine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Isoxsuprine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Isoxsuprine Market report?

Ans: The main players in the Isoxsuprine Market are Pharco, Invision Pharma, Zenon Healthcare, Systemic, Wockhardt, Solvay Pharma, Glenmark, Bristol-Myers Squibb, Merck Sharp and Dohme, Amriya, Pfizer, Winston Pharma, Johnson and Johnson, Aspen Pharmacare, Abbott, Drugmaker's Laboratoires

What are the Application segmentation covered in the Isoxsuprine Market report?

Ans: The Applications covered in the Isoxsuprine Market report are Peripheral Vasodilator, β-Sympathomimetic Agent

What are the Type segmentation covered in the Isoxsuprine Market report?

Ans: The Types covered in the Isoxsuprine Market report are Use in Humans, Use in Animals

1 Isoxsuprine Market Overview
1.1 Product Definition
1.2 Isoxsuprine by Type
1.2.1 Global Isoxsuprine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Use in Humans
1.2.3 Use in Animals
1.3 Isoxsuprine by Application
1.3.1 Global Isoxsuprine Market Value by Application (2024 VS 2031)
1.3.2 Peripheral Vasodilator
1.3.3 β-Sympathomimetic Agent
1.4 Global Isoxsuprine Market Size Estimates and Forecasts
1.4.1 Global Isoxsuprine Revenue 2020-2031
1.4.2 Global Isoxsuprine Sales 2020-2031
1.4.3 Global Isoxsuprine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Isoxsuprine Market Competition by Manufacturers
2.1 Global Isoxsuprine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Isoxsuprine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Isoxsuprine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Isoxsuprine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Isoxsuprine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Isoxsuprine, Product Type & Application
2.7 Global Key Manufacturers of Isoxsuprine, Date of Enter into This Industry
2.8 Global Isoxsuprine Market Competitive Situation and Trends
2.8.1 Global Isoxsuprine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Isoxsuprine Players Market Share by Revenue
2.8.3 Global Isoxsuprine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Isoxsuprine Market Scenario by Region
3.1 Global Isoxsuprine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Isoxsuprine Sales by Region: 2020-2031
3.2.1 Global Isoxsuprine Sales by Region: 2020-2025
3.2.2 Global Isoxsuprine Sales by Region: 2026-2031
3.3 Global Isoxsuprine Revenue by Region: 2020-2031
3.3.1 Global Isoxsuprine Revenue by Region: 2020-2025
3.3.2 Global Isoxsuprine Revenue by Region: 2026-2031
3.4 North America Isoxsuprine Market Facts & Figures by Country
3.4.1 North America Isoxsuprine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Isoxsuprine Sales by Country (2020-2031)
3.4.3 North America Isoxsuprine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Isoxsuprine Market Facts & Figures by Country
3.5.1 Europe Isoxsuprine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Isoxsuprine Sales by Country (2020-2031)
3.5.3 Europe Isoxsuprine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Isoxsuprine Market Facts & Figures by Region
3.6.1 Asia Pacific Isoxsuprine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Isoxsuprine Sales by Region (2020-2031)
3.6.3 Asia Pacific Isoxsuprine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Isoxsuprine Market Facts & Figures by Country
3.7.1 Latin America Isoxsuprine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Isoxsuprine Sales by Country (2020-2031)
3.7.3 Latin America Isoxsuprine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Isoxsuprine Market Facts & Figures by Country
3.8.1 Middle East and Africa Isoxsuprine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Isoxsuprine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Isoxsuprine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Isoxsuprine Sales by Type (2020-2031)
4.1.1 Global Isoxsuprine Sales by Type (2020-2025)
4.1.2 Global Isoxsuprine Sales by Type (2026-2031)
4.1.3 Global Isoxsuprine Sales Market Share by Type (2020-2031)
4.2 Global Isoxsuprine Revenue by Type (2020-2031)
4.2.1 Global Isoxsuprine Revenue by Type (2020-2025)
4.2.2 Global Isoxsuprine Revenue by Type (2026-2031)
4.2.3 Global Isoxsuprine Revenue Market Share by Type (2020-2031)
4.3 Global Isoxsuprine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Isoxsuprine Sales by Application (2020-2031)
5.1.1 Global Isoxsuprine Sales by Application (2020-2025)
5.1.2 Global Isoxsuprine Sales by Application (2026-2031)
5.1.3 Global Isoxsuprine Sales Market Share by Application (2020-2031)
5.2 Global Isoxsuprine Revenue by Application (2020-2031)
5.2.1 Global Isoxsuprine Revenue by Application (2020-2025)
5.2.2 Global Isoxsuprine Revenue by Application (2026-2031)
5.2.3 Global Isoxsuprine Revenue Market Share by Application (2020-2031)
5.3 Global Isoxsuprine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pharco
6.1.1 Pharco Company Information
6.1.2 Pharco Description and Business Overview
6.1.3 Pharco Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pharco Isoxsuprine Product Portfolio
6.1.5 Pharco Recent Developments/Updates
6.2 Invision Pharma
6.2.1 Invision Pharma Company Information
6.2.2 Invision Pharma Description and Business Overview
6.2.3 Invision Pharma Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Invision Pharma Isoxsuprine Product Portfolio
6.2.5 Invision Pharma Recent Developments/Updates
6.3 Zenon Healthcare
6.3.1 Zenon Healthcare Company Information
6.3.2 Zenon Healthcare Description and Business Overview
6.3.3 Zenon Healthcare Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zenon Healthcare Isoxsuprine Product Portfolio
6.3.5 Zenon Healthcare Recent Developments/Updates
6.4 Systemic
6.4.1 Systemic Company Information
6.4.2 Systemic Description and Business Overview
6.4.3 Systemic Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Systemic Isoxsuprine Product Portfolio
6.4.5 Systemic Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Company Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wockhardt Isoxsuprine Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Solvay Pharma
6.6.1 Solvay Pharma Company Information
6.6.2 Solvay Pharma Description and Business Overview
6.6.3 Solvay Pharma Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Solvay Pharma Isoxsuprine Product Portfolio
6.6.5 Solvay Pharma Recent Developments/Updates
6.7 Glenmark
6.7.1 Glenmark Company Information
6.7.2 Glenmark Description and Business Overview
6.7.3 Glenmark Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Glenmark Isoxsuprine Product Portfolio
6.7.5 Glenmark Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Isoxsuprine Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Merck Sharp and Dohme
6.9.1 Merck Sharp and Dohme Company Information
6.9.2 Merck Sharp and Dohme Description and Business Overview
6.9.3 Merck Sharp and Dohme Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Sharp and Dohme Isoxsuprine Product Portfolio
6.9.5 Merck Sharp and Dohme Recent Developments/Updates
6.10 Amriya
6.10.1 Amriya Company Information
6.10.2 Amriya Description and Business Overview
6.10.3 Amriya Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Amriya Isoxsuprine Product Portfolio
6.10.5 Amriya Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Isoxsuprine Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Winston Pharma
6.12.1 Winston Pharma Company Information
6.12.2 Winston Pharma Description and Business Overview
6.12.3 Winston Pharma Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Winston Pharma Isoxsuprine Product Portfolio
6.12.5 Winston Pharma Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Company Information
6.13.2 Johnson and Johnson Description and Business Overview
6.13.3 Johnson and Johnson Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Johnson and Johnson Isoxsuprine Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Aspen Pharmacare
6.14.1 Aspen Pharmacare Company Information
6.14.2 Aspen Pharmacare Description and Business Overview
6.14.3 Aspen Pharmacare Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Aspen Pharmacare Isoxsuprine Product Portfolio
6.14.5 Aspen Pharmacare Recent Developments/Updates
6.15 Abbott
6.15.1 Abbott Company Information
6.15.2 Abbott Description and Business Overview
6.15.3 Abbott Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Abbott Isoxsuprine Product Portfolio
6.15.5 Abbott Recent Developments/Updates
6.16 Drugmaker's Laboratoires
6.16.1 Drugmaker's Laboratoires Company Information
6.16.2 Drugmaker's Laboratoires Description and Business Overview
6.16.3 Drugmaker's Laboratoires Isoxsuprine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Drugmaker's Laboratoires Isoxsuprine Product Portfolio
6.16.5 Drugmaker's Laboratoires Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Isoxsuprine Industry Chain Analysis
7.2 Isoxsuprine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Isoxsuprine Production Mode & Process Analysis
7.4 Isoxsuprine Sales and Marketing
7.4.1 Isoxsuprine Sales Channels
7.4.2 Isoxsuprine Distributors
7.5 Isoxsuprine Customer Analysis
8 Isoxsuprine Market Dynamics
8.1 Isoxsuprine Industry Trends
8.2 Isoxsuprine Market Drivers
8.3 Isoxsuprine Market Challenges
8.4 Isoxsuprine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Isoxsuprine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Isoxsuprine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Isoxsuprine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Isoxsuprine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Isoxsuprine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Isoxsuprine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Isoxsuprine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Isoxsuprine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Isoxsuprine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Isoxsuprine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Isoxsuprine, Product Type & Application
 Table 12. Global Key Manufacturers of Isoxsuprine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Isoxsuprine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoxsuprine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Isoxsuprine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Isoxsuprine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Isoxsuprine Sales Market Share by Region (2020-2025)
 Table 19. Global Isoxsuprine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Isoxsuprine Sales Market Share by Region (2026-2031)
 Table 21. Global Isoxsuprine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Isoxsuprine Revenue Market Share by Region (2020-2025)
 Table 23. Global Isoxsuprine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Isoxsuprine Revenue Market Share by Region (2026-2031)
 Table 25. North America Isoxsuprine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Isoxsuprine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Isoxsuprine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Isoxsuprine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Isoxsuprine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Isoxsuprine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Isoxsuprine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Isoxsuprine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Isoxsuprine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Isoxsuprine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Isoxsuprine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Isoxsuprine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Isoxsuprine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Isoxsuprine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Isoxsuprine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Isoxsuprine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Isoxsuprine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Isoxsuprine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Isoxsuprine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Isoxsuprine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Isoxsuprine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Isoxsuprine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Isoxsuprine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Isoxsuprine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Isoxsuprine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Isoxsuprine Sales (K Units) by Type (2020-2025)
 Table 51. Global Isoxsuprine Sales (K Units) by Type (2026-2031)
 Table 52. Global Isoxsuprine Sales Market Share by Type (2020-2025)
 Table 53. Global Isoxsuprine Sales Market Share by Type (2026-2031)
 Table 54. Global Isoxsuprine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Isoxsuprine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Isoxsuprine Revenue Market Share by Type (2020-2025)
 Table 57. Global Isoxsuprine Revenue Market Share by Type (2026-2031)
 Table 58. Global Isoxsuprine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Isoxsuprine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Isoxsuprine Sales (K Units) by Application (2020-2025)
 Table 61. Global Isoxsuprine Sales (K Units) by Application (2026-2031)
 Table 62. Global Isoxsuprine Sales Market Share by Application (2020-2025)
 Table 63. Global Isoxsuprine Sales Market Share by Application (2026-2031)
 Table 64. Global Isoxsuprine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Isoxsuprine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Isoxsuprine Revenue Market Share by Application (2020-2025)
 Table 67. Global Isoxsuprine Revenue Market Share by Application (2026-2031)
 Table 68. Global Isoxsuprine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Isoxsuprine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pharco Company Information
 Table 71. Pharco Description and Business Overview
 Table 72. Pharco Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pharco Isoxsuprine Product
 Table 74. Pharco Recent Developments/Updates
 Table 75. Invision Pharma Company Information
 Table 76. Invision Pharma Description and Business Overview
 Table 77. Invision Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Invision Pharma Isoxsuprine Product
 Table 79. Invision Pharma Recent Developments/Updates
 Table 80. Zenon Healthcare Company Information
 Table 81. Zenon Healthcare Description and Business Overview
 Table 82. Zenon Healthcare Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zenon Healthcare Isoxsuprine Product
 Table 84. Zenon Healthcare Recent Developments/Updates
 Table 85. Systemic Company Information
 Table 86. Systemic Description and Business Overview
 Table 87. Systemic Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Systemic Isoxsuprine Product
 Table 89. Systemic Recent Developments/Updates
 Table 90. Wockhardt Company Information
 Table 91. Wockhardt Description and Business Overview
 Table 92. Wockhardt Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Wockhardt Isoxsuprine Product
 Table 94. Wockhardt Recent Developments/Updates
 Table 95. Solvay Pharma Company Information
 Table 96. Solvay Pharma Description and Business Overview
 Table 97. Solvay Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Solvay Pharma Isoxsuprine Product
 Table 99. Solvay Pharma Recent Developments/Updates
 Table 100. Glenmark Company Information
 Table 101. Glenmark Description and Business Overview
 Table 102. Glenmark Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Glenmark Isoxsuprine Product
 Table 104. Glenmark Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Isoxsuprine Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Merck Sharp and Dohme Company Information
 Table 111. Merck Sharp and Dohme Description and Business Overview
 Table 112. Merck Sharp and Dohme Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Merck Sharp and Dohme Isoxsuprine Product
 Table 114. Merck Sharp and Dohme Recent Developments/Updates
 Table 115. Amriya Company Information
 Table 116. Amriya Description and Business Overview
 Table 117. Amriya Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Amriya Isoxsuprine Product
 Table 119. Amriya Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Pfizer Isoxsuprine Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Winston Pharma Company Information
 Table 126. Winston Pharma Description and Business Overview
 Table 127. Winston Pharma Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Winston Pharma Isoxsuprine Product
 Table 129. Winston Pharma Recent Developments/Updates
 Table 130. Johnson and Johnson Company Information
 Table 131. Johnson and Johnson Description and Business Overview
 Table 132. Johnson and Johnson Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Johnson and Johnson Isoxsuprine Product
 Table 134. Johnson and Johnson Recent Developments/Updates
 Table 135. Aspen Pharmacare Company Information
 Table 136. Aspen Pharmacare Description and Business Overview
 Table 137. Aspen Pharmacare Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Aspen Pharmacare Isoxsuprine Product
 Table 139. Aspen Pharmacare Recent Developments/Updates
 Table 140. Abbott Company Information
 Table 141. Abbott Description and Business Overview
 Table 142. Abbott Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Abbott Isoxsuprine Product
 Table 144. Abbott Recent Developments/Updates
 Table 145. Drugmaker's Laboratoires Company Information
 Table 146. Drugmaker's Laboratoires Description and Business Overview
 Table 147. Drugmaker's Laboratoires Isoxsuprine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Drugmaker's Laboratoires Isoxsuprine Product
 Table 149. Drugmaker's Laboratoires Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Isoxsuprine Distributors List
 Table 153. Isoxsuprine Customers List
 Table 154. Isoxsuprine Market Trends
 Table 155. Isoxsuprine Market Drivers
 Table 156. Isoxsuprine Market Challenges
 Table 157. Isoxsuprine Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Isoxsuprine
 Figure 2. Global Isoxsuprine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Isoxsuprine Market Share by Type: 2024 & 2031
 Figure 4. Use in Humans Product Picture
 Figure 5. Use in Animals Product Picture
 Figure 6. Global Isoxsuprine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Isoxsuprine Market Share by Application: 2024 & 2031
 Figure 8. Peripheral Vasodilator
 Figure 9. β-Sympathomimetic Agent
 Figure 10. Global Isoxsuprine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Isoxsuprine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Isoxsuprine Sales (2020-2031) & (K Units)
 Figure 13. Global Isoxsuprine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Isoxsuprine Report Years Considered
 Figure 15. Isoxsuprine Sales Share by Manufacturers in 2024
 Figure 16. Global Isoxsuprine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Isoxsuprine Players: Market Share by Revenue in Isoxsuprine in 2024
 Figure 18. Isoxsuprine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Isoxsuprine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Isoxsuprine Sales Market Share by Country (2020-2031)
 Figure 21. North America Isoxsuprine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Isoxsuprine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Isoxsuprine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Isoxsuprine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Isoxsuprine Revenue Market Share by Region (2020-2031)
 Figure 33. China Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Isoxsuprine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Isoxsuprine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Isoxsuprine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Isoxsuprine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Isoxsuprine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Isoxsuprine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Isoxsuprine by Type (2020-2031)
 Figure 54. Global Isoxsuprine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Isoxsuprine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Isoxsuprine by Application (2020-2031)
 Figure 57. Global Isoxsuprine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Isoxsuprine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart